Focal HDR brachytherapy boost to stereotactic radiotherapy (fBTsRT) for prostate cancer: a phase II randomized controlled trial

被引：0
|
作者：
C. Belliveau
M. Barkati
G. Delouya
D. Taussky
M. C. Beauchemin
C. Lambert
L. Beaulieu
D. Beliveau-Nadeau
B. Nicolas
J. F. Carrier
E. Vigneault
C. Ménard
机构：
[1] CHUM - Centre Hospitalier de l’Université de Montréal,Radiation Oncology
[2] Université Laval,Radiation Oncology, Centre universitaire de Québec
来源：
Radiation Oncology | / 17卷
关键词：
Prostate cancer; Stereotactic radiotherapy; Focal brachytherapy; Quality of life; Magnetic resonance imaging;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Radiotherapy of local prostate cancer in combination with interstitial HDR brachytherapy
    Heil, T
    Lemnitzer, H
    Kloetzer, KH
    Hoffmann, L
    STRAHLENTHERAPIE UND ONKOLOGIE, 2002, 178 : 42 - 42
  • [32] Stereotactic body radiotherapy (SBRT) versus high dose rate (HDR) brachytherapy (BT) boost for high-risk (HR) prostate cancer.
    Gonzalez-Motta, Alejandro
    Roach, Mack
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [33] HDR brachytherapy Monotherapy for prostate cancer: a one-day schedule phase II trial acute toxicity
    Jolicoeur, M.
    Nguyen, T. V.
    Derashodian, T.
    Hill, E.
    Mondat, M.
    Nachabe, M.
    Antebi, E.
    Wakil, G.
    Heliou, R.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S139 - S140
  • [34] A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer
    S. Kawakami
    H. Tsumura
    T. Satoh
    K. Tabata
    A. Sekiguchi
    T. Kainuma
    M. Nakano
    M. Iwamura
    H. Ishiyama
    Radiation Oncology, 17
  • [35] A phase II trial of stereotactic body radiotherapy in 4 fractions for patients with localized prostate cancer
    Kawakami, S.
    Tsumura, H.
    Satoh, T.
    Tabata, K.
    Sekiguchi, A.
    Kainuma, T.
    Nakano, M.
    Iwamura, M.
    Ishiyama, H.
    RADIATION ONCOLOGY, 2022, 17 (01)
  • [36] Linac-based stereotactic radiotherapy for prostate cancer: preliminary analysis of a phase II trial
    Ciliberti, M. P.
    Carbonara, R.
    Gregucci, F.
    Surgo, A.
    Scarcia, M.
    Caliandro, M.
    Di Guglielmo, F. C.
    Paulicelli, E.
    Ludovico, G. M.
    Bonaparte, I.
    Fiorentino, A.
    RADIOTHERAPY AND ONCOLOGY, 2023, 182 : S1204 - S1205
  • [37] SINGLE FRACTION HDR BRACHYTHERAPY AS ANTICIPATED BOOST IN LOCALIZED PROSTATE CANCER
    Cerrotta, A.
    Fallai, C.
    Carrara, M.
    Borroni, M.
    Villa, S.
    Bedini, N.
    Garcia, M.
    Maucione, A.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S288 - S289
  • [38] Results of high dose rate (HDR) brachytherapy boost for prostate cancer
    Kelly, D
    Flynn, J
    Brookover, W
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 : S18 - S18
  • [39] COMBINED RADIOTHERAPY OF PROSTATE CANCER: HDR BOOST VS LDR BOOST.
    Albitskiy, I.
    Vinikovetskaya, A.
    RADIOTHERAPY AND ONCOLOGY, 2011, 99 : S281 - S281
  • [40] Re: Patterns of Failure Following External Beam Radiotherapy With or Without an Additional Focal Boost in the Randomized Controlled FLAME Trial for Localized Prostate Cancer
    Taneja, Samir S.
    JOURNAL OF UROLOGY, 2023, 209 (06): : 1230 - 1231
12345